Abstract A030 Secondary malignancies after radiotherapy treatment of pediatric cancer patients in Egypt over a six-year period

Abstract Background: Pediatric cancer survivors are at risk of developing secondary malignant neoplasms (SMNs) due to exposure to prior treatment modalities, including radiotherapy (RT). We conducted a retrospective cohort study to examine whether initial RT dose was associated with a greater risk of developing SMNs among pediatric cancer patients in Egypt. Methods: We identified patients (8 days-18 years at enrollment in care) who had received RT for treating primary cancer at Children’s Cancer Hospital (CCHE) in Cairo, Egypt, between 2009 and 2015. Patients were classified into two exposure groups based on the median initial RT course dosage, where ≤3600 centrigray (cGy) and >3600 cGy were considered low and high RT exposure, respectively. The cumulative incidence of SMN accounting for the competing risk of death was compared by initial RT dose using the cumulative incidence function, and multivariable sub-distributional hazard (SHR) models were fitted to compare the hazards of SMN for children with low vs high initial RT dose. Results: Of the 3,132 patients included in this study, 60.1% were male and the median age at enrollment in care was 6.2 years (interquartile range: 3.5-10.7). Approximately half (50.6%) of the patients received a low initial RT dose. The cumulative incidence of SMN at 11.1 years was 3.05% (95% CI 1.15-5.93%) overall and 3.92% (95% CI 1.19-9.39%) and 2.01% (95% CI 0.77-4.38%) for low and high RT dose patients, respectively. Children who received high initial RT doses did not have higher hazards of developing SMN in bivariable (SHR 0.55, 95% CI 0.32-1.75) and multivariable models (aSHR 0.25, 95% CI 0.04-1.70). Conclusion: In this cohort of pediatric cancer patients in Egypt, high initial RT dose was not associated with increased hazards of SMN. Future research should extend follow-up time after the first decade following an initial cancer diagnosis to capture a more complete picture of SMN incidence. Other initiatives may include establishing national cancer registries in low- to middle-income countries to better track longitudinal cancer data in these populations. Citation Format: Charlotte L. Sackett, Mohamed S Zaghloul, Ahmed Aldesouky, Amr S Soliman, Chloe A. Teasdale. Secondary malignancies after radiotherapy treatment of pediatric cancer patients in Egypt over a six-year period [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Pediatric Cancer Research; 2024 Sep 5-8; Toronto, Ontario, Canada. Philadelphia (PA): AACR; Cancer Res 2024;84(17 Suppl):Abstract nr A030.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2024-09-05
DOI
https://doi.org/10.1158/1538-7445.pediatric24-a030
Citations
1
Primary Topic
Multiple and Secondary Primary Cancers
Type
article
Field-Weighted Citation Impact
0.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract A030 Secondary malignancies after radiotherapy treatment of pediatric cancer patients in Egypt over a six-year period

Amr S. Soliman, Chloe A. Teasdale, Mohamed Zaghloul, Charlotte Sackett et al.
1 citations
Cancer Research
Multiple and Secondary Primary Cancers
0.39
article

Abstract A030 Secondary malignancies after radiotherapy treatment of pediatric cancer patients in Egypt over a six-year period

Amr S. Soliman, Chloe A. Teasdale, Mohamed Zaghloul, Charlotte Sackett, Ahmed Aldesouky
article en
1 citations

Abstract

Abstract Background: Pediatric cancer survivors are at risk of developing secondary malignant neoplasms (SMNs) due to exposure to prior treatment modalities, including radiotherapy (RT). We conducted a retrospective cohort study to examine whether initial RT dose was associated with a greater risk of developing SMNs among pediatric cancer patients in Egypt. Methods: We identified patients (8 days-18 years at enrollment in care) who had received RT for treating primary cancer at Children’s Cancer Hospital (CCHE) in Cairo, Egypt, between 2009 and 2015. Patients were classified into two exposure groups based on the median initial RT course dosage, where ≤3600 centrigray (cGy) and >3600 cGy were considered low and high RT exposure, respectively. The cumulative incidence of SMN accounting for the competing risk of death was compared by initial RT dose using the cumulative incidence function, and multivariable sub-distributional hazard (SHR) models were fitted to compare the hazards of SMN for children with low vs high initial RT dose. Results: Of the 3,132 patients included in this study, 60.1% were male and the median age at enrollment in care was 6.2 years (interquartile range: 3.5-10.7). Approximately half (50.6%) of the patients received a low initial RT dose. The cumulative incidence of SMN at 11.1 years was 3.05% (95% CI 1.15-5.93%) overall and 3.92% (95% CI 1.19-9.39%) and 2.01% (95% CI 0.77-4.38%) for low and high RT dose patients, respectively. Children who received high initial RT doses did not have higher hazards of developing SMN in bivariable (SHR 0.55, 95% CI 0.32-1.75) and multivariable models (aSHR 0.25, 95% CI 0.04-1.70). Conclusion: In this cohort of pediatric cancer patients in Egypt, high initial RT dose was not associated with increased hazards of SMN. Future research should extend follow-up time after the first decade following an initial cancer diagnosis to capture a more complete picture of SMN incidence. Other initiatives may include establishing national cancer registries in low- to middle-income countries to better track longitudinal cancer data in these populations. Citation Format: Charlotte L. Sackett, Mohamed S Zaghloul, Ahmed Aldesouky, Amr S Soliman, Chloe A. Teasdale. Secondary malignancies after radiotherapy treatment of pediatric cancer patients in Egypt over a six-year period [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Pediatric Cancer Research; 2024 Sep 5-8; Toronto, Ontario, Canada. Philadelphia (PA): AACR; Cancer Res 2024;84(17 Suppl):Abstract nr A030.

Cancer ResearchVol. 84(17_Supplement)
University of Southern California (US), City University of New York (US), Children Cancer Hospital (EG)
Openalex Percentile: Top 35%
Multiple and Secondary Primary Cancers
0.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.